Insider Transactions in Q2 2025 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,676
-2.79%
|
$12,676
$1.65 P/Share
|
|
Jun 30
2025
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
3,581
-2.62%
|
$3,581
$1.65 P/Share
|
|
Jun 30
2025
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,453
-2.0%
|
$2,453
$1.65 P/Share
|
|
Jun 30
2025
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,420
-2.89%
|
$3,420
$1.65 P/Share
|
|
Jun 02
2025
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,681
+1.88%
|
$0
$0.81 P/Share
|
|
Jun 02
2025
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
BUY
Grant, award, or other acquisition
|
Direct |
1,145
+0.83%
|
$0
$0.81 P/Share
|